Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
RELMADA THERAPEUTICS, INC. (RLMD)
Sector: Healthcare; Industry: Drug Manufacturers—Specialty & Generic

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, is being developed as a rapidly acting, oral agent for the treatment of depression, neuropathic pain, and/or other potential CNS pathological conditions. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in New York, New York.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-07-15 CASAMENTO CHARLES J Director Sell 3,300 $31.54 $104,088 No
2021-06-01 CASAMENTO CHARLES J Director Sell 3,000 $33.34 $100,020 No
2021-05-03 CASAMENTO CHARLES J Director Sell 3,000 $38.22 $114,647 No
2021-04-01 CASAMENTO CHARLES J Director Sell 3,000 $35.43 $106,281 No
2021-03-10 TRAVERSA SERGIO CEO Sell 10,000 $35.48 $354,845 Yes
2021-03-09 Kelly Paul Edward Director Sell 5,000 $35.71 $178,551 Yes
2021-03-10 Shenouda Maged CFO Sell 10,000 $35.45 $354,507 Yes
2021-03-01 CASAMENTO CHARLES J Director Sell 3,000 $33.87 $101,618 No
2021-02-24 TRAVERSA SERGIO CEO Sell 10,000 $34.24 $342,392 Yes
2021-02-24 Kelly Paul Edward Director Sell 5,000 $34.19 $170,933 Yes
2021-02-11 TRAVERSA SERGIO CEO Sell 1,446 $35.43 $51,238 Yes
2021-02-11 Shenouda Maged CFO Sell 1,428 $35.39 $50,542 Yes
2021-02-10 TRAVERSA SERGIO CEO Sell 11,206 $35.17 $394,085 Yes
2021-02-09 Kelly Paul Edward Director Sell 3,569 $35.18 $125,565 Yes
2021-02-10 Shenouda Maged CFO Sell 11,372 $35.17 $399,910 Yes
2021-02-03 TRAVERSA SERGIO CEO Sell 3,278 $35.07 $114,970 Yes
2021-02-03 Shenouda Maged CFO Sell 3,200 $35.04 $112,134 Yes
2021-02-02 Kelly Paul Edward Director Sell 2,346 $35.04 $82,203 Yes
2021-02-01 CASAMENTO CHARLES J Director Sell 3,000 $33.63 $100,898 No
2021-01-27 Shenouda Maged CFO Sell 3,000 $31.93 $95,778 Yes
2021-01-27 TRAVERSA SERGIO CEO Sell 10,000 $32.39 $323,914 Yes
2021-01-27 Kelly Paul Edward Director Sell 5,000 $32.46 $162,323 Yes
2021-01-22 Kelly Paul Edward Director Sell 1,800 $35.43 $63,774 No
2021-01-26 Kelly Paul Edward Director Sell 4,085 $1580.95 $6,458,190 Yes
2021-01-26 TRAVERSA SERGIO CEO Sell 4,070 $35.43 $144,180 Yes
2021-01-26 Shenouda Maged CFO Sell 4,000 $35.40 $141,612 Yes
2021-01-04 CASAMENTO CHARLES J Director Sell 3,000 $32.11 $96,342 No
2020-12-01 CASAMENTO CHARLES J Director Sell 3,000 $35.74 $107,219 No
2020-11-02 CASAMENTO CHARLES J Director Sell 3,000 $30.29 $90,864 No
2020-10-01 CASAMENTO CHARLES J Director Sell 3,000 $37.99 $113,956 No

Insider Smart

Upwork Inc (UPWK) - GRETSCH GREGORY C. Director of Upwork, made a bulk buy of 500K shares right before the big gap up, which is also the largest buy of the past 12 months.

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.